Format

Send to

Choose Destination
J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1097-104. doi: 10.1093/gerona/glv057. Epub 2015 Jul 17.

A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity.

Collaborators (191)

Ravussin E, Champagne C, Gupta A, Martin C, Redman L, Smith S, Williamson D, Martin C, Begnaud M, Cerniauskas B, Davis A, Gabrielle J, Walden H, Currier N, Shipp M, Masters S, McNicoll M, Prince S, Brock C, Puyau R, Earnest C, Rood J, Stewart T, Levitan L, Traylor C, Thomas S, Toups V, Jones K, Tatum S, Waguespack C, Crotwell K, Dalfrey L, Braymer A, Hilliard R, Thomas O, Arceneaux J, LaPrarie S, Strate A, Ihrig J, Mancuso S, Beard C, Hymel A, Shepard D, Correa J, Jarreau D, Dahmer B, Bella G, Soroe E, Conner B, McCown P, Anaya S, Lupo M, Roberts SB, Das SK, Meydani S, Fielding R, Greenberg I, Pittas A, Saltzman E, Scott T, Gilhooly C, Gerber K, Greenberg I, Kaplan M, Karabetian C, Kennedy R, Robinson L, Bembridge V, Berlis M, Buer S, Carabello R, Campbell C, Collins L, Doherty M, Freed A, Hernandez C, Jean-Baptiste G, Krasinski M, Lim-Lucas M, Maslova E, Maxwell B, McShea J, Muchowski A, Mulkerrin M, Murphy K, Nelsen C, O'Neill M, Rasmussen H, Roche B, Roman E, Sproull G, Victor MS, Storer S, Strissel K, Valliere S, Vilme M, Wheeler J, Wiley J, Yangarber F, Holloszy JO, Fontana L, Klein S, Lambert C, Mohammed BS, Racette S, Villareal D, Stein R, Cotton K, Hof M, Massmann C, Obert K, Pearlman M, Reising TM, Weber L, Uhrich M, Schram M, Meyer M, Carlen C, Kee L, Larson B, McFerson M, Sabatino R, Toennies B, Rochon J, Bales CW, Pieper CF, Kraus W, Galan KM, Adrian R, Allen EL, Blasko W, Bhapkar M, Brown N, Butts M, Cossin EK, Curry J, Daniel J, Diemer KS, Greiner L, Johnson D, Jones C, Lindblad L, McAdams L, Mansfield M, Murugesan S, Piner L, Plummer C, Revoir M, Smith P, Spaulding M, Topping J, Wong WW, Clarke LL, Liu CW, Fraley J, Schwartz AV, Shepherd J, Palermo L, Ewing S, Rahorst M, Navy C, Lewis M, Tracy RP, Boyle R, Cornell E, Daunais P, Draayer D, Floersch M, Gagne N, Keating F, Patnoad A, Schmidt M, Gavin M, Wiener F, Hughes A, Benken L, Otto A, Halter J, Buchner DM, Elmer P, Espeland M, Heymsfield SB, Pi-Sunyer X, Prohaska T, Shapses S, Speakman J, Weindruch R, Hadley EC, Hannah J, Romashkan S, Evans M.

Author information

1
Pennington Biomedical Research Center, Baton Rouge, Louisiana. ehadley@nih.gov.
2
Pennington Biomedical Research Center, Baton Rouge, Louisiana.
3
Duke Clinical Research Institute and Duke University School of Medicine, Durham, North Carolina. Rho Federal Systems, Chapel Hill, North Carolina.
4
Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts.
5
Duke Clinical Research Institute and Duke University School of Medicine, Durham, North Carolina.
6
National Institute on Aging, Bethesda, Maryland.
7
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
8
Pennington Biomedical Research Center, Baton Rouge, Louisiana. Translational Research Institute for Metabolism and Diabetes, Florida Hospital and Sanford Burnham Medical Research Institute, Orlando.

Erratum in

  • Errata. [J Gerontol A Biol Sci Med Sci. 2016]

Abstract

BACKGROUND:

Caloric restriction (CR), energy intake reduced below ad libitum (AL) intake, increases life span in many species. The implications for humans can be clarified by randomized controlled trials of CR.

METHODS:

To determine CR's feasibility, safety, and effects on predictors of longevity, disease risk factors, and quality of life in nonobese humans aged 21-51 years, 218 persons were randomized to a 2-year intervention designed to achieve 25% CR or to AL diet. Outcomes were change from baseline resting metabolic rate adjusted for weight change ("RMR residual") and core temperature (primary); plasma triiodothyronine (T3) and tumor necrosis factor-α (secondary); and exploratory physiological and psychological measures.

RESULTS:

Body mass index averaged 25.1 (range: 21.9-28.0 kg/m(2)). Eighty-two percent of CR and 95% of AL participants completed the protocol. The CR group achieved 11.7±0.7 %CR (mean ± standard error) and maintained 10.4±0.4% weight loss. Weight change in AL was negligible. RMR residual decreased significantly more in CR than AL at 12 months (p = .04) but not 24 months (M24). Core temperature change differed little between groups. T3 decreased more in CR at M12 and M24 (p < .001), while tumor necrosis factor-α decreased significantly more only at M24 (p = .02). CR had larger decreases in cardiometabolic risk factors and in daily energy expenditure adjusted for weight change, without adverse effects on quality of life.

CONCLUSIONS:

Sustained CR is feasible in nonobese humans. The effects of the achieved CR on correlates of human survival and disease risk factors suggest potential benefits for aging-related outcomes that could be elucidated by further human studies.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT00427193.

KEYWORDS:

Biomarkers; Caloric restriction; Metabolism; Nutrition; Risk factors

Comment in

PMID:
26187233
PMCID:
PMC4841173
DOI:
10.1093/gerona/glv057
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center